Doctors are lowering LDL cholesterol levels to prevent heart attacks and reduce cardiac risks in millions of people ...

Please provide your email address to receive an email when new articles are posted on . CETP inhibition may help high-risk patients reach their LDL goals and reduce risk for atherosclerotic CVD events ...

ApoB testing outperforms traditional cholesterol measures in preventing heart attacks and strokes while remaining ...

Merck’s experimental oral PCSK9 inhibitor, enlicitide decanoate, achieved unprecedented LDL cholesterol reductions in a phase 3 head-to-head trial against leading non-statin drugs. The results arrive ...

A South Korean trial has shown that aiming for LDL cholesterol levels below 55 mg/dL in high-risk heart patients reduced major cardiovascular events by a third compared to the less than 70 mg/dL ...

Cholesterol testing should begin as early as age 10, new guidelines suggest. The American Heart Association, along with 10 other leading medical groups, recently issued new guidelines for managing ...

New recommendations suggest that some people should start trying to lower their cholesterol as early as age 30.

Cholesterol is an important parameter for heart health If you get confused with the test results we have simplified them for ...

An experimental pill called enlicitide was found to dramatically lower LDL (“bad”) cholesterol by ~60% in a large phase 3 clinical trial. The study enrolled nearly 2,900 adults already on statins who ...

You have had the cholesterol conversation with your doctor enough times that the numbers feel familiar. LDL, HDL, triglycerides. Good and bad. High and low. The problem is that after 60, the ...

Every 40 seconds, someone in the U.S. has a heart attack or stroke, and in most cases, it’s their first. 1 The good news? The risk for these devastating events can actually be significantly reduced by ...